TipRanks
Go Ultimate55% OFF

Medicus Pharma Ltd (MDCX) Ownership - Who Owns Medicus Pharma Ltd?

Medicus Pharma Ltd (MDCX) Ownership Overview

  • 11.57% Insiders
  • <0.01% Mutual Funds
  • 2.84% Other Institutional Investors
  • 85.58% Public Companies and Individual Investors

The ownership structure of Medicus Pharma Ltd (MDCX) stock is a mix of institutional, retail, and individual investors. Approximately 2.85% of the company’s stock is owned by Institutional Investors, 11.57% is owned by Insiders, and 85.58% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

MDCX top shareholders
Holder# of SharesType% HoldingValue
Carolyn F. Bonner1,489,493Insider78.73%2,800,247
Faisal Mehmud1,470,588Insider77.73%2,764,705
Andrew Alasdair Smith735,458Insider38.88%1,382,661
Edward J. Brennan674,735Insider35.67%1,268,502

FAQ

Who Owns Medicus Pharma Ltd (MDCX)?
According to the latest TipRanks data, approximately 2.85% of the company's stock is held by institutional investors, 11.57% is held by insiders, and 85.58% is held by public companies and individual investors.
What percentage of Medicus Pharma Ltd (MDCX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.85% of Medicus Pharma Ltd (MDCX) stock is held by institutional investors: <0.01% by mutual funds and 2.84% by other institutional investors.
What percentage of Medicus Pharma Ltd (MDCX) stock is held by retail investors?
According to the latest TipRanks data, approximately 85.58% of Medicus Pharma Ltd (MDCX) stock is held by public companies and individual investors.
Who owns the most shares of Medicus Pharma Ltd (MDCX)?
Carolyn F. Bonner owns the most shares of Medicus Pharma Ltd (MDCX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.